Best time for treatment in serious pulmonary embolism
Part of Heart & circulation, Lungs & breathing clinical trials.
This trial looks at when it's best to give treatment to restore blood flow in people with a serious type of pulmonary embolism. It aims to find the optimal time for this procedure to improve outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a confirmed diagnosis of intermediate-high or high-risk pulmonary embolism.
- Your condition is classified as high-risk or intermediate-high-risk using standard guidelines.
- You are able to give informed consent for your data to be used.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well a catheter (a thin tube) works to treat a serious type of blood clot in the lungs. It is for people who have a large clot that is causing problems like fast heart rate or low blood pressure.
This study looks at how certain blood test results and heart ultrasound measurements relate to the severity of a blood clot in the lungs. It may help doctors better understand how to treat people with this condition.
This trial tests whether a standard procedure using a catheter to deliver clot-dissolving medicine directly into the lung artery works well for people with a serious but not immediately life-threatening blood clot in the lungs (pulmonary embolism). It aims to improve heart function and reduce long-term complications.
This trial compares a lower dose of the clot-dissolving medicine alteplase to the standard full dose for people with a severe pulmonary embolism (a blood clot in the lungs). The goal is to see if the lower dose is just as safe and effective, with fewer bleeding risks.
This trial tests a treatment that uses ultrasound to guide a thin tube (catheter) to deliver clot-busting medicine directly into the blood clot in your lung. It may be an option for people whose clot is serious but not yet causing shock, and who have symptoms that started within the last two weeks.
This trial tests three ways of using a catheter (a thin tube) to remove or break up blood clots in the lungs for people with a serious but stable type of pulmonary embolism. The goal is to find the best approach to improve recovery and reduce complications.
Hear when a new Pulmonary Embolism (Diagnosis) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.